[The use of complex interval models for predicting activity of non-nucleoside reverse transcriptase activity]

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Virology

Context:

• The ongoing search for effective anti-HIV agents remains critical.
• Non-nucleoside reverse transcriptase inhibitors (NNRTIs) represent a modern, less toxic class of anti-HIV drugs.
• Developing new NNRTIs is essential due to their favorable metabolic stability and reduced toxicity compared to nucleoside analogues.

Purpose:

• To present a predictive approach for anti-HIV activity based on structure-activity relationship (SAR) models.
• To utilize computational methods for estimating the potential inhibitory activity of novel compounds.
• To reduce the high costs associated with synthesizing and testing new anti-HIV drug candidates.

Summary:

• This research introduces a predictive method for estimating the anti-HIV activity of compounds.
• The approach employs structure-activity models built on calculated descriptor domains for energetically allowed conformers.
• The predictive power was demonstrated using Tetrahydroimidazobenzodiazipenone (TIBO) and Phenylethyltiazolyltiourea (PETT) derivatives.

Impact:

• The developed method accurately predicts inhibitory activity, aligning with experimental findings.
• This approach enables the prediction of activity for compounds not included in the initial training set.
• The technique offers a cost-effective strategy for accelerating the discovery of novel anti-HIV agents.